Agentix Corp. (AGTX) Executive Compensation
Agentix Corp. (AGTX) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AGTX
CIK: 1603345
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 03/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Fruci & Associates II, PLLC
Auditor SinceSince 8/31/2019 12:00:00 AM
Lead Engagement PartnerJulie Wilson
Audit LocationSpokane, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | FORM 10-Q | 0001477932-26-004781 | View SEC Doc Filr Page |
| 10-K | 2026-07-01 | 2026-03-31 | FORM 10-K | 0001477932-26-004133 | View SEC Doc Filr Page |
| 10-Q | 2026-02-17 | 2025-12-31 | FORM 10-Q | 0001477932-26-000845 | View SEC Doc Filr Page |
| 10-Q | 2025-11-20 | 2025-09-30 | FORM 10-Q | 0001477932-25-008502 | View SEC Doc Filr Page |
| 10-Q | 2025-08-22 | 2025-06-30 | FORM 10-Q | 0001477932-25-006197 | View SEC Doc Filr Page |
| NT 10-Q | 2025-08-15 | 2025-06-30 | NT 10-Q | 0001477932-25-005988 | View SEC Doc Filr Page |
| 10-K | 2025-07-16 | 2025-03-31 | FORM 10-K | 0001477932-25-005077 | View SEC Doc Filr Page |
| NT 10-K | 2025-07-01 | 2025-03-31 | FORM NT 10-K | 0001477932-25-004870 | View SEC Doc Filr Page |
| 10-Q | 2025-02-18 | 2024-12-31 | FORM 10-Q | 0001477932-25-001090 | View SEC Doc Filr Page |
| NT 10-Q | 2025-02-14 | 2024-12-31 | NT 10-Q | 0001477932-25-001033 | View SEC Doc Filr Page |
| 10-Q | 2024-11-18 | 2024-09-30 | FORM 10-Q | 0001477932-24-007361 | View SEC Doc Filr Page |
| NT 10-Q | 2024-11-14 | 2024-09-30 | NT 10-Q | 0001477932-24-007174 | View SEC Doc Filr Page |
| 10-Q | 2024-09-25 | 2024-06-30 | FORM 10-Q | 0001477932-24-005905 | View SEC Doc Filr Page |
| 10-K | 2024-08-30 | 2024-03-31 | FORM 10-K | 0001477932-24-005401 | View SEC Doc Filr Page |
| NT 10-Q | 2024-08-15 | 2024-06-30 | NT 10-Q | 0001477932-24-004932 | View SEC Doc Filr Page |
| NT 10-K | 2024-07-01 | 2024-03-31 | NT 10-K | 0001477932-24-003980 | View SEC Doc Filr Page |
| 10-Q | 2024-02-14 | 2023-12-31 | FORM 10-Q | 0001477932-24-000711 | View SEC Doc Filr Page |
| 10-Q | 2023-11-20 | 2023-09-30 | FORM 10-Q | 0001477932-23-008660 | View SEC Doc Filr Page |
| NT 10-Q | 2023-11-14 | 2023-09-30 | NT 10-Q | 0001477932-23-008377 | View SEC Doc Filr Page |
| 10-Q | 2023-08-22 | 2023-06-30 | FORM 10-Q | 0001477932-23-006393 | View SEC Doc Filr Page |
| NT 10-Q | 2023-08-14 | 2023-06-30 | NT 10-Q | 0001477932-23-006049 | View SEC Doc Filr Page |
| 10-K | 2023-07-14 | 2023-03-31 | FORM 10-K | 0001477932-23-005252 | View SEC Doc Filr Page |
| NT 10-K | 2023-06-29 | 2023-03-31 | NT 10-K | 0001477932-23-004881 | View SEC Doc Filr Page |
| 10-Q | 2023-02-14 | 2022-12-31 | FORM 10-Q | 0001477932-23-000969 | View SEC Doc Filr Page |
| 10-Q | 2022-11-14 | 2022-09-30 | FORM 10-Q | 0001477932-22-008435 | View SEC Doc Filr Page |